Barely Significant
← all excerpts

Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer.

Biomark Res · 2025 · PMC11773940 · PMID 39871312

Europe PMCDOI
1
hedged sentence
0.0550
closest p · 1.1× alpha
0.0550
boldest claim

The sentences

nearly significantp = 0.055so close (0.05 < p ≤ 0.1)
Consistently, mice treated with chemo > STING/α-PD-1 + α-CTLA-4 had significantly better survival than STING/α-PD-1 + α-CTLA-4 ( p = 0.034) while mice treated with chemo > NLRP3/α-PD-1 + α-CTLA-4 had better survival, which was nearly significant ( p = 0.055), than NLRP3/α-PD-1 + α-CTLA-4 (Fig. 2 C).

also in 3,349 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.